Published on 27 Apr 2024 on Simply Wall St. via Yahoo Finance
As you might know, AstraZeneca PLC (LON:AZN) just kicked off its latest quarterly results with some very strong numbers. The company beat expectations with revenues of US$13b arriving 7.2% ahead of forecasts. Statutory earnings per share (EPS) were US$1.41, 6.3% ahead of estimates. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
See our latest analysis for AstraZeneca
earnings-and-revenue-growth